Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Psychiatry
  4. Depression
  5. Drugs

Drugs

  • ADHD (63)
  • Anxiety (25)
  • Bipolar Disorder (15)
  • Depression (214)
    • Cardiovascular Disease and Depression (4)
    • Drugs (190)
      • Atypical Antipsychotics (55)
      • Benzodiazepines (40)
      • Bupropion (44)
      • MAOIs (14)
      • SNRIs (82)
      • SSRIs (94)
      • TCAs (38)
      • Typical Antipsychotics (4)
    • Natural Medicines/Supplements (12)
    • Pediatrics (15)
    • Post-Traumatic Stress Disorder (8)
    • Pregnancy (8)
    • Seasonal Affective Disorder (7)
    • Treatment-Resistant Depression (17)
  • Mental Health (22)
  • Resources (127)
  • Schizophrenia (55)
  • Sleep Disorders (84)
  • Substance Use Disorder (221)
151 - 165 of 190 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: confusion about which bupropion to dispense February 2011
Article: The new drug, Latuda (lurasidone), will compete in a crowded market of "atypical" antipsychotics (Zyprexa, Abilify, Invega, etc) February 2011
Archive: A Note from Your Pharmacist: How to Write for Bupropion to Get the Product You Want February 2011
Article: more prescriptions for Cymbalta (duloxetine) December 2010
Article: avoiding errors with antidepressants November 2010
Guideline: Practice Guideline for the Treatment of Patients With Major Depressive Disorder (2010) November 2010
Commentary: Depression Guidelines: Overview of Pharmacotherapy November 2010
Article: Silenor (SI-leh-nor) and Oleptro (oh-LEP-tro) are two NEW formulations of the OLD drugs doxepin and trazodone October 2010
Commentary: Oleptro (Trazodone) and Silenor (Doxepin) October 2010
Article: New generic versions of venlafaxine will create MORE confusion August 2010
Chart: Comparison of Venlafaxine and Desvenlafaxine August 2010
Chart: State Regulations on Generic Substitution August 2010
Article: "QT prolongation" drug interaction alerts May 2010
Article: increasing use of antipsychotics (Abilify, Zyprexa, Risperdal, etc) in children January 2010
Article: Saphris (SA-fris), a new antipsychotic October 2009
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved